FindTrial
Sign In

Study on the Intervention Mechanism of Compound Danshen Dropping Pills on diabetes Retinopathy Based on Retinal Organ Model

Study on the Intervention Mechanism of Compound Danshen Dropping Pills on diabetes Retinopathy Based on Retinal Organ Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108522
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes, newly diagnosed patients with severe NPDR and PDR

Interventions

Observation group:None
Control group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes, aged 18~75 years; 2. Patients with newly diagnosed severe NPDR and PDR; 3. Best corrected visual acuity (BCVA) between 20/40 and 20/320; 4. Glycated hemoglobin (HbA1c) <=10%;

Exclusion criteria

Exclusion criteria: 1. Previous panretinal photocoagulation therapy; 2. Vitreous hemorrhage seriously affects fundus examination; 3. Retinal detachment; 4. Anti-VEGF therapy in the past 3 months; 5. Severe liver and kidney insufficiency; 6. Pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
Differential gene expression in diabetes retinopathy;—

Countries

China

Contacts

Public ContactJiaoyue Zhang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

zhangjiaoyue@126.com+86 18627829527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026